A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis

NCT02188771 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DEVICE: intra-articular administration of RegenoGel-SP or hyaluronic acid (HA)

Sponsor

ProCore Ltd.